vs
First Bancorp, Inc（FNLC）与ARS Pharmaceuticals, Inc.（SPRY）财务数据对比。点击上方公司名可切换其他公司
ARS Pharmaceuticals, Inc.的季度营收约是First Bancorp, Inc的1.1倍（$28.1M vs $25.8M），First Bancorp, Inc净利率更高（39.4% vs -147.1%，领先186.5%），First Bancorp, Inc同比增速更快（17.5% vs -67.6%）
第一银行公司（First Bancorp, Inc）是一家银行控股公司，其核心业务通过总部位于康涅狄格州斯坦福的爱国者国家银行（Patriot Bank NA）开展，相关 banking 业务也以PNBK代码在纳斯达克挂牌交易。
ARS Pharmaceuticals是一家处于后期研发阶段的生物制药企业，专注于开发和商业化严重过敏反应创新疗法，核心产品为无需注射的肾上腺素鼻腔递送制剂，主要面向北美市场，服务存在致命过敏风险的成人及儿童患者群体。
FNLC vs SPRY — 直观对比
营收规模更大
SPRY
是对方的1.1倍
$25.8M
营收增速更快
FNLC
高出85.1%
-67.6%
净利率更高
FNLC
高出186.5%
-147.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $25.8M | $28.1M |
| 净利润 | $10.2M | $-41.3M |
| 毛利率 | — | — |
| 营业利润率 | 48.1% | -147.6% |
| 净利率 | 39.4% | -147.1% |
| 营收同比 | 17.5% | -67.6% |
| 净利润同比 | 39.7% | -182.8% |
| 每股收益（稀释后） | $0.91 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FNLCSPRY
| Q4 25 | $25.8M | $28.1M | ||
| Q3 25 | $24.5M | $32.5M | ||
| Q2 25 | $22.5M | $15.7M | ||
| Q1 25 | $21.8M | $8.0M | ||
| Q4 24 | $22.0M | $86.6M | ||
| Q3 24 | $20.5M | $2.1M | ||
| Q2 24 | $19.2M | $500.0K | ||
| Q1 24 | $18.5M | $0 |
净利润FNLCSPRY
| Q4 25 | $10.2M | $-41.3M | ||
| Q3 25 | $9.1M | $-51.2M | ||
| Q2 25 | $8.1M | $-44.9M | ||
| Q1 25 | $7.1M | $-33.9M | ||
| Q4 24 | $7.3M | $49.9M | ||
| Q3 24 | $7.6M | $-19.1M | ||
| Q2 24 | $6.2M | $-12.5M | ||
| Q1 24 | $6.0M | $-10.3M |
营业利润率FNLCSPRY
| Q4 25 | 48.1% | -147.6% | ||
| Q3 25 | 45.2% | -163.7% | ||
| Q2 25 | 43.7% | -302.9% | ||
| Q1 25 | 39.3% | -466.3% | ||
| Q4 24 | 39.5% | 54.5% | ||
| Q3 24 | 44.6% | -1051.6% | ||
| Q2 24 | 38.8% | -3068.0% | ||
| Q1 24 | 39.3% | — |
净利率FNLCSPRY
| Q4 25 | 39.4% | -147.1% | ||
| Q3 25 | 37.0% | -157.4% | ||
| Q2 25 | 35.8% | -285.6% | ||
| Q1 25 | 32.5% | -425.7% | ||
| Q4 24 | 33.1% | 57.7% | ||
| Q3 24 | 36.9% | -925.0% | ||
| Q2 24 | 32.1% | -2503.2% | ||
| Q1 24 | 32.5% | — |
每股收益（稀释后）FNLCSPRY
| Q4 25 | $0.91 | $-0.41 | ||
| Q3 25 | $0.81 | $-0.52 | ||
| Q2 25 | $0.72 | $-0.46 | ||
| Q1 25 | $0.63 | $-0.35 | ||
| Q4 24 | $0.66 | $0.52 | ||
| Q3 24 | $0.68 | $-0.20 | ||
| Q2 24 | $0.55 | $-0.13 | ||
| Q1 24 | $0.54 | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $245.0M |
| 总债务越低越好 | $95.5M | $96.4M |
| 股东权益账面价值 | $283.1M | $114.3M |
| 总资产 | $3.2B | $327.7M |
| 负债/权益比越低杠杆越低 | 0.34× | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资FNLCSPRY
| Q4 25 | — | $245.0M | ||
| Q3 25 | — | $288.2M | ||
| Q2 25 | — | $240.1M | ||
| Q1 25 | — | $275.7M | ||
| Q4 24 | — | $314.0M | ||
| Q3 24 | — | $204.6M | ||
| Q2 24 | — | $218.7M | ||
| Q1 24 | — | $223.6M |
总债务FNLCSPRY
| Q4 25 | $95.5M | $96.4M | ||
| Q3 25 | $95.5M | $96.2M | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $70.0M | — | ||
| Q4 24 | $95.0M | $0 | ||
| Q3 24 | $95.0M | — | ||
| Q2 24 | $70.0M | — | ||
| Q1 24 | $70.0M | — |
股东权益FNLCSPRY
| Q4 25 | $283.1M | $114.3M | ||
| Q3 25 | $274.6M | $147.7M | ||
| Q2 25 | $265.5M | $192.3M | ||
| Q1 25 | $259.7M | $229.0M | ||
| Q4 24 | $252.5M | $256.8M | ||
| Q3 24 | $256.8M | $201.0M | ||
| Q2 24 | $244.7M | $215.2M | ||
| Q1 24 | $242.6M | $223.9M |
总资产FNLCSPRY
| Q4 25 | $3.2B | $327.7M | ||
| Q3 25 | $3.2B | $372.8M | ||
| Q2 25 | $3.2B | $313.5M | ||
| Q1 25 | $3.2B | $327.3M | ||
| Q4 24 | $3.2B | $351.2M | ||
| Q3 24 | $3.1B | $217.6M | ||
| Q2 24 | $3.1B | $222.0M | ||
| Q1 24 | $3.0B | $227.6M |
负债/权益比FNLCSPRY
| Q4 25 | 0.34× | 0.84× | ||
| Q3 25 | 0.35× | 0.65× | ||
| Q2 25 | 0.36× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.38× | 0.00× | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.29× | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $37.8M | $-43.5M |
| 自由现金流经营现金流 - 资本支出 | $34.6M | — |
| 自由现金流率自由现金流/营收 | 133.9% | — |
| 资本支出强度资本支出/营收 | 12.5% | 0.0% |
| 现金转化率经营现金流/净利润 | 3.72× | — |
| 过去12个月自由现金流最近4个季度 | $55.3M | — |
8季度趋势，按日历期对齐
经营现金流FNLCSPRY
| Q4 25 | $37.8M | $-43.5M | ||
| Q3 25 | $12.9M | $-47.0M | ||
| Q2 25 | $7.4M | $-39.6M | ||
| Q1 25 | $2.2M | $-40.7M | ||
| Q4 24 | $26.0M | $42.0M | ||
| Q3 24 | $9.8M | $-14.5M | ||
| Q2 24 | $6.4M | $-7.3M | ||
| Q1 24 | $-1.5M | $-6.7M |
自由现金流FNLCSPRY
| Q4 25 | $34.6M | — | ||
| Q3 25 | $12.6M | $-47.2M | ||
| Q2 25 | $7.2M | $-39.6M | ||
| Q1 25 | $828.0K | $-40.8M | ||
| Q4 24 | $24.6M | $41.7M | ||
| Q3 24 | $9.6M | $-14.6M | ||
| Q2 24 | $6.3M | $-7.3M | ||
| Q1 24 | $-1.8M | $-6.8M |
自由现金流率FNLCSPRY
| Q4 25 | 133.9% | — | ||
| Q3 25 | 51.4% | -145.4% | ||
| Q2 25 | 32.1% | -252.2% | ||
| Q1 25 | 3.8% | -512.1% | ||
| Q4 24 | 111.7% | 48.2% | ||
| Q3 24 | 47.0% | -706.3% | ||
| Q2 24 | 32.9% | -1463.4% | ||
| Q1 24 | -9.8% | — |
资本支出强度FNLCSPRY
| Q4 25 | 12.5% | 0.0% | ||
| Q3 25 | 1.2% | 0.6% | ||
| Q2 25 | 0.6% | 0.3% | ||
| Q1 25 | 6.2% | 1.1% | ||
| Q4 24 | 6.7% | 0.3% | ||
| Q3 24 | 0.5% | 6.8% | ||
| Q2 24 | 0.3% | 7.6% | ||
| Q1 24 | 1.8% | — |
现金转化率FNLCSPRY
| Q4 25 | 3.72× | — | ||
| Q3 25 | 1.42× | — | ||
| Q2 25 | 0.91× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 3.58× | 0.84× | ||
| Q3 24 | 1.29× | — | ||
| Q2 24 | 1.03× | — | ||
| Q1 24 | -0.25× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FNLC
暂无分部数据
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
